Amid layoff fears, AstraZeneca stakes a ‘For Sale’ sign on US campus
After culling workers in Boston and Maryland, AstraZeneca is considering its options for its US headquarters campus in Delaware. The local papers have been reporting that the pharma giant has decided to put its HQ up for sale, but is looking for a deal to lease it back.
Back in May the company triggered fears of a looming restructuring that would likely trigger job cuts on the 30-acre site after a spokesperson confirmed that it was considering selling the site and moving to a new location in the state.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.